Garet C Comer, MD
Hand Surgery · Mountain View
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 2
- 2 carriers
- Offices
- 5
Offices
5 locations · Sutter Bay Medical Foundation · 3,783 clinicians in this group
Hospitals listed: El Camino Health. That is not proof they admit you there this week.
Plans that list them
2 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Comer’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
2 of 2 plans
| Alignment Health Sutter Advantage +More (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence A116877 · Current
Licensed to practise in California · since 2011 · expires 2027-03-31 · University of Texas Medical Branch at Galveston.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- El Camino HealthMountain View, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of El Camino Health, which runs 2 hospitalsPatients rate it 4 of 5 · 80% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.291, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.393, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0, Oct 2024 – Sep 2025
See every measure and the patient survey for El Camino Health
Behind the star rating — Deaths: 3 better, 5 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 1 better, 9 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.291 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.393 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.96 (0.12 to 1.79) · 2,340 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.02 (0.76 to 1.28) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 167.38 (125.03 to 209.73) · 96 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.6 · 68 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 185 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.9 · 814 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13 · 842 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.6 · 361 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.6 · 4,633 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.34) · 11,474 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.1 to 0.45) · 11,626 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.14 (1.39 to 4.9) · 2,814 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2 (0.61 to 3.39) · 1,327 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.8 to 3.43) · 2,641 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.39 (4.18 to 14.6) · 1,287 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.57 (3.47 to 9.68) · 1,308 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.14 (0.71 to 3.57) · 827 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.6 (0.05 to 1.15) · 9,460 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.5 · 122 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.993 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.706 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.376 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.5 · 218 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.5 · 962 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 3.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -17 · 922 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 18.6 · 860 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.7 · 827 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.1 (4.5 to 8.2) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 13.4 (10.6 to 16.5) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.1 · 144 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.3 · 80 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.7 · 237 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.8 (10 to 16.1) · 1,639 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.8 to 1.1) · 1,619 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,535 patients answered, 22% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 75% |
| Nurses "always" listened carefully | 76% |
| Nurses "always" treated them with courtesy and respect | 87% |
| "Always" quiet at night | 47% |
| "YES", patients would definitely recommend the hospital | 80% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
Original Medicare doctor bills
$145,891
Medicare paid this office $145,891 for 455 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Short return visit (20+ min) | 208 | $23,323 | $83 |
| New patient visit (30+ min) | 208 | $20,157 | $97 |
| Incision of tendon covering of finger | 30 | $19,445 | $572 |
| Release and/or relocation of hand nerve | 16 | $7,269 | $454 |
| Injection into tendon or ligament | 59 | $3,817 | $51 |
See all 15 services
| Short return visit (20+ min) | 208 | $23,323 | $83 |
| New patient visit (30+ min) | 208 | $20,157 | $97 |
| Incision of tendon covering of finger | 30 | $19,445 | $572 |
| Release and/or relocation of hand nerve | 16 | $7,269 | $454 |
| Injection into tendon or ligament | 59 | $3,817 | $51 |
| New patient visit (45+ min) | 25 | $3,605 | $144 |
| Fluoroscopic guidance for needle placement | 19 | $3,119 | $120 |
| Aspiration and/or injection of fluid from small joint | 32 | $2,109 | $54 |
| Injection of carpal tunnel | 16 | $1,542 | $77 |
| Return visit (30+ min) | 14 | $1,386 | $99 |
| Application of elbow to finger cast | 15 | $1,354 | $90 |
| Aspiration and/or injection of fluid from medium joint | 13 | $997 | $59 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 12 | $881 | $73 |
| Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | 116 | $806 | None |
| Cast supplies, short arm cast, adult (11 years +), fiberglass | 14 | $261 | $19 |
Procedures Medicare counted
| Removal of nail tissue | 1-10 | None |
| Removal of tissue | 1-10 | None |
Who their Medicare patients are
455 Original Medicare patients in 2024. Average age 76 · Women 63% · Also on Medicaid 8% · Health risk score 0.94. At or below the middle of the specialty; the typical hand surgery clinician is at 1.08.
Conditions among them: High blood pressure 65% · Diabetes 22% · Coronary heart disease 20% · Chronic kidney disease 17% · Depression 15% · Atrial fibrillation 14% · Cancer 13% · Heart failure 11% · COPD 8% · Dementia 4% · Stroke 4%.
The office billed $660,813, Medicare allowed $190,096 and paid $145,891; for 1,110 services of 70 kinds; $827 of it was for drugs given in the office and $145,064 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 455 | 1,110 | 76 | 0.94 | $660,813 | $145,891 |
| 2023 | 522 | 1,344 | 76 | 0.81 | $756,998 | $173,631 |
| 2022 | 482 | 1,486 | 76 | 0.92 | $750,500 | $178,204 |
| 2021 | 319 | 968 | 76 | 1.09 | $548,807 | $134,382 |
| 2020 | 286 | 778 | 75 | 0.93 | $464,884 | $104,825 |
| 2019 | 417 | 1,060 | 76 | 1.00 | $626,845 | $143,680 |
| 2018 | 296 | 787 | 75 | 1.04 | $378,334 | $89,773 |
| 2017 | 250 | 634 | 76 | 1.04 | $369,806 | $88,612 |
| 2016 | 127 | 291 | 76 | 1.07 | $173,466 | $33,489 |
| 2015 | 39 | 49 | 71 | 1.50 | $83,597 | $4,719 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 13 services
| Short return visit (20+ min) | 235 | $24,867 | $80 |
| New patient visit (30+ min) | 243 | $22,968 | $95 |
| Incision of tendon covering of finger | 33 | $22,904 | $603 |
| Release and/or relocation of hand nerve | 23 | $9,953 | $415 |
| New patient visit (45+ min) | 57 | $8,438 | $148 |
| Injection into tendon or ligament | 93 | $6,049 | $50 |
| Return visit (30+ min) | 56 | $5,985 | $105 |
| Fluoroscopic guidance for needle placement | 18 | $2,292 | $104 |
| Aspiration and/or injection of fluid from small joint | 22 | $1,452 | $52 |
| Application of elbow to finger cast | 14 | $1,210 | $86 |
| Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | 143 | $921 | None |
| Aspiration and/or injection of fluid from medium joint | 13 | $741 | $49 |
| Cast supplies, short arm cast, adult (11 years +), fiberglass | 13 | $236 | $18 |
2022: 15 services
| New patient visit (30+ min) | 208 | $20,272 | $97 |
| Short return visit (20+ min) | 174 | $19,312 | $81 |
| Incision of tendon covering of finger | 25 | $18,822 | $554 |
| New patient visit (45+ min) | 71 | $10,641 | $150 |
| Return visit (30+ min) | 79 | $9,426 | $112 |
| Injection into tendon or ligament | 83 | $5,254 | $47 |
| Release and/or relocation of hand nerve | 12 | $4,595 | $383 |
| Fluoroscopic guidance for needle placement | 17 | $2,822 | $128 |
| Aspiration and/or injection of fluid from small joint | 25 | $1,594 | $53 |
| Application of elbow to finger cast | 18 | $1,480 | $82 |
| Injection of carpal tunnel | 15 | $1,363 | $80 |
| Application of nonmoveable forearm to hand splint | 14 | $1,007 | $67 |
| Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | 133 | $980 | None |
| Cast supplies, short arm cast, adult (11 years +), fiberglass | 18 | $303 | $17 |
| Cast supplies, short arm splint, adult (11 years +), fiberglass | 13 | $147 | $10 |
2021: 10 services
| Short return visit (20+ min) | 110 | $13,206 | $84 |
| New patient visit (30+ min) | 117 | $11,838 | $101 |
| Incision of tendon covering of finger | 17 | $11,469 | $573 |
| Return visit (30+ min) | 70 | $8,427 | $114 |
| New patient visit (45+ min) | 52 | $8,063 | $155 |
| Injection into tendon or ligament | 42 | $2,815 | $52 |
| Fluoroscopic guidance for needle placement | 12 | $1,524 | $127 |
| Aspiration and/or injection of fluid from medium joint | 11 | $776 | $55 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 11 | $728 | $66 |
| Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | 67 | $529 | None |
2020: 10 services
| Incision of tendon covering of finger | 19 | $12,220 | $531 |
| New patient visit (30+ min) | 103 | $8,905 | $86 |
| Short return visit (20+ min) | 93 | $7,375 | $65 |
| Release and/or relocation of hand nerve | 16 | $6,674 | $417 |
| Return visit (30+ min) | 72 | $6,175 | $85 |
| Short return visit | 53 | $2,357 | $37 |
| Injection into tendon or ligament | 37 | $2,169 | $45 |
| Injection of carpal tunnel | 12 | $993 | $76 |
| Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | 70 | $613 | None |
| Aspiration and/or injection of fluid from medium joint | 11 | $565 | $47 |
2019: 14 services
| New patient visit (30+ min) | 165 | $15,266 | $93 |
| Short return visit (20+ min) | 139 | $12,554 | $67 |
| Return visit (30+ min) | 121 | $11,963 | $99 |
| Incision of tendon covering of finger | 19 | $10,944 | $521 |
| Release and/or relocation of hand nerve | 15 | $6,607 | $413 |
| Injection into tendon or ligament | 46 | $3,188 | $47 |
| Short return visit | 31 | $1,494 | $44 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 15 | $1,368 | $91 |
| Application of elbow to finger cast | 11 | $1,035 | $86 |
| Aspiration and/or injection of fluid from large joint | 13 | $931 | $58 |
| Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | 97 | $816 | None |
| Injection into tendon at attachment to bone or muscle | 12 | $591 | $42 |
| Aspiration and/or injection of fluid from small joint | 11 | $557 | $43 |
| Cast supplies, short arm cast, adult (11 years +), fiberglass | 11 | $189 | $16 |
2018: 9 services
| Return visit (30+ min) | 106 | $10,033 | $94 |
| Short return visit (20+ min) | 102 | $9,941 | $64 |
| New patient visit (30+ min) | 113 | $9,259 | $82 |
| Release and/or relocation of hand nerve | 19 | $8,532 | $388 |
| Application of elbow to finger cast | 19 | $1,924 | $84 |
| Injection into tendon or ligament | 28 | $1,405 | $44 |
| Short return visit | 17 | $767 | $43 |
| Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | 56 | $558 | None |
| Cast supplies, short arm cast, adult (11 years +), fiberglass | 19 | $353 | $15 |
2017: 9 services
| Return visit (30+ min) | 92 | $8,297 | $90 |
| New patient visit (30+ min) | 88 | $8,138 | $92 |
| Short return visit (20+ min) | 81 | $7,967 | $63 |
| Incision of tendon covering of finger | 13 | $7,306 | $522 |
| Injection into tendon or ligament | 25 | $1,355 | $41 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 11 | $1,342 | $122 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 12 | $1,077 | $90 |
| Short return visit | 16 | $716 | $42 |
| Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | 44 | $338 | None |
2016: 4 services
| New patient visit (30+ min) | 52 | $5,016 | $96 |
| Short return visit (20+ min) | 52 | $4,459 | $65 |
| Return visit (30+ min) | 41 | $3,867 | $94 |
| Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | 22 | $137 | None |
2015: 2 services
| New patient visit (30+ min) | 11 | $749 | $68 |
| Short return visit (20+ min) | 11 | $548 | $46 |
Money from drug and device companies
$68 in 2025
| 2025 | 2 | 2 | None | $68 |
| 2024 | 1 | 1 | None | $47 |
| 2020 | 1 | 1 | None | $32 |
| 2019 | 3 | 4 | None | $255 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Axogen | None | $55 | 1 payment
|
| Trice Medical | None | $13 | 1 payment
|
See all 2 published payments
| Axogen | Meals · 2025-09-29 | None | $55 |
| Trice Medical | Meals · 2025-05-02 | None | $13 |
See earlier years (2024, 2020, 2019)
2024: $47
| Axogen | Avance Nerve Graft | $47 | 1 payment
|
2020: $32
| Axogen | Avance Nerve Graft | $32 | 1 payment
|
2019: $255
| Medical Device Business Services | Headless Compression Screws | $114 | 1 payment
|
| Acumed | Acutrak Headless Compression Screw System | $93 | 1 payment
|
| Axogen | Axoguard Nerve Connector | $49 | 2 payments
|
Professional record
- NPI
- 1659507804
- Licence
- CA A116877California A116877: Current · expires 2027-03-31
- Trained
- University of Texas Medical Branch at Galveston, 2009
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207XS0106X (207XS0106X)
- Mailing address
- 325 Distel Cir, Los Altos, CA, 94022
- NPI first listed
- 2009-06-02
- NPI last updated
- 2020-12-10
- NPI record certified
- 2020-12-10
This is when the NPI record was last certified, not a medical board exam.